Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib) combination therapy is projected to increase overall survival (OS) by ...

As with other drugs, Rybrevant (amivantamab-vmjw) can cause side effects, such as rash, nausea, and fatigue. If you are not able to tolerate side effects of Rybrevant, talk with your doctor or ...

Johnson & Johnson's hopes of quickly building its new cancer drug Rybrevant into a $5 billion ... That includes a need for split dosing in some cases, prolonged infusion times, and infusion ...